Naor joins the company after serving as CFO at surgical solutions provider Axogen. His financial background includes leading the sale of Arbor Pharmaceuticals to Azurity Pharmaceuticals during his tenure there as finance chief. His extensive resume also spans leadership roles at the U.S. and Americas divisions of Mölnlycke, alongside prior experience at AstraZeneca, UCB, and KPMG.
Simultaneous with the leadership transition in the finance department, Neuronetics announced that Andrew Macan, the company's executive vice president, chief legal officer, and corporate secretary, will resign from his positions on August 15.

Comments (0)
No comments yet. Be the first!